Literature DB >> 20528231

Future of oncologic photodynamic therapy.

Ron R Allison1, Vanderlei S Bagnato, Claudio H Sibata.   

Abstract

Photodynamic therapy (PDT) is a tumor-ablative and function-sparing oncologic intervention. The relative simplicity of photosensitizer application followed by light activation resulting in the cytotoxic and vasculartoxic photodynamic reaction has allowed PDT to reach a worldwide audience. With several commercially available photosensitizing agents now on the market, numerous well designed clinical trials have demonstrated the efficacy of PDT on various cutaneous and deep tissue tumors. However, current photosensitizers and light sources still have a number of limitations. Future PDT will build on those findings to allow development and refinement of more optimal therapeutic agents and illumination devices. This article reviews the current state of the art and limitations of PDT, and highlight the progress being made towards the future of oncologic PDT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528231     DOI: 10.2217/fon.10.51

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  16 in total

1.  Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.

Authors:  Alyssa M Master; Megan Livingston; Nancy L Oleinick; Anirban Sen Gupta
Journal:  Mol Pharm       Date:  2012-07-19       Impact factor: 4.939

2.  Effect of light polarization on the efficiency of photodynamic therapy of basal cell carcinomas: an in vitro cellular study.

Authors:  M JalalKamali; S N Nematollahi-Mahani; M Shojaei; A Shamsoddini; N Arabpour
Journal:  Lasers Med Sci       Date:  2017-11-15       Impact factor: 3.161

3.  Photosensitizer Activation Drives Apoptosis by Interorganellar Ca2+ Transfer and Superoxide Production in Bystander Cancer Cells.

Authors:  Chiara Nardin; Chiara Peres; Flavia Mazzarda; Gaia Ziraldo; Anna Maria Salvatore; Fabio Mammano
Journal:  Cells       Date:  2019-09-29       Impact factor: 6.600

Review 4.  Photodynamic therapy: one step ahead with self-assembled nanoparticles.

Authors:  Pinar Avci; S Sibel Erdem; Michael R Hamblin
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

5.  Thermosensitive liposome formulated indocyanine green for near-infrared triggered photodynamic therapy: in vivo evaluation for triple-negative breast cancer.

Authors:  Colby S Shemesh; Delaram Moshkelani; Hailing Zhang
Journal:  Pharm Res       Date:  2014-11-19       Impact factor: 4.200

6.  Discovery of the Antitumor Effects of a Porphyrazine Diol (Pz 285) in MDA-MB-231 Breast Tumor Xenograft Models in Mice.

Authors:  Irawati K Kandela; Katherine J McAuliffe; Lauren E Cochran; Anthony G M Barrett; Brian M Hoffman; Andrew P Mazar; Evan R Trivedi
Journal:  ACS Med Chem Lett       Date:  2017-06-29       Impact factor: 4.345

7.  RUNX3 confers sensitivity to pheophorbide a-photodynamic therapy in human oral squamous cell carcinoma cell lines.

Authors:  Sook Moon; Jung Yoon Bae; Hwa-Kyung Son; Doo Young Lee; Gyeongju Park; Hyun You; Hyojin Ko; Yong-Chul Kim; Jin Kim
Journal:  Lasers Med Sci       Date:  2013-05-23       Impact factor: 3.161

8.  Cellular stress induced by photodynamic reaction with CoTPPS and MnTMPyPCl5 in combination with electroporation in human colon adenocarcinoma cell lines (LoVo and LoVoDX).

Authors:  J Kulbacka; M Kotulska; N Rembiałkowska; A Choromańska; I Kamińska; A Garbiec; J Rossowska; M Daczewska; B Jachimska; J Saczko
Journal:  Cell Stress Chaperones       Date:  2013-04-18       Impact factor: 3.667

Review 9.  Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors.

Authors:  Mingying Yang; Tao Yang; Chuanbin Mao
Journal:  Angew Chem Int Ed Engl       Date:  2019-07-10       Impact factor: 15.336

10.  Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma.

Authors:  Pawel Mroz; Yumin Xia; Daisuke Asanuma; Aaron Konopko; Timur Zhiyentayev; Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Usman J Khan; Tim Wharton; Michael R Hamblin
Journal:  Nanomedicine       Date:  2011-05-19       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.